KD

Karla Drescher

Abbott: 33 patents #106 of 5,431Top 2%
AD Abb Vie Deutschland: 19 patents #12 of 274Top 5%
AV Abb Vie: 17 patents #60 of 1,257Top 5%
Basf Se: 2 patents #5,851 of 13,826Top 45%
AB AbbVie: 1 patents #860 of 1,308Top 70%
Overall (All Time): #51,051 of 4,157,543Top 2%
52
Patents All Time

Issued Patents All Time

Showing 25 most recent of 52 patents

Patent #TitleCo-InventorsDate
10308610 Inhibitor compounds of phosphodiesterase type 10A Hervé Geneste, Michael Ochse, Jurgen Dinges, Clarissa Jakob 2019-06-04
10118926 Tricyclic quinoline and quinoxaline derivatives Hannes Fiepko KOOLMAN, Wilfried Braje, Helmut Mack, Andreas Haupt, Ana-Lucia Relo +5 more 2018-11-06
9994568 Tricyclic quinoline and quinoxaline derivatives Hannes Fiepko KOOLMAN, Wilfried Braje, Helmut Mack, Andreas Haupt, Ana-Lucia Relo +3 more 2018-06-12
9938269 Inhibitor compounds of phosphodiesterase type 10A Hervé Geneste, Michael Ochse, Berthold Behl, Loic Laplanche, Jurgen Dinges +2 more 2018-04-10
9856220 Inhibitor compounds of phosphodiesterase type 10A Hervé Geneste, Michael Ochse, Jurgen Dinges, Clarissa Jakob 2018-01-02
9790203 Inhibitor compounds of phosphodiesterase type 10A Hervé Geneste, Sean Colm Turner, Michael Ochse, Lawrence A. Black, Katja Jantos 2017-10-17
9657034 Substituted furo[3,2-c]pyridines, thieno[3,2-c]pyridines, thieno[2,3-d]pyridazines and pyrido[3,4-d]pyridazines as phosphodiesterase type 10A inhibitors Hervé Geneste, Michael Ochse, Sean Colm Turner, Berthold Behl, Loic Laplanche +4 more 2017-05-23
9573950 Substituted [1,4]diazepino[6,7,1-ij]quinolines as serotonin 5-HT2C receptor modulators Gisela Backfisch, Margaretha Henrica Maria Bakker, Günter BLAICH, Wilfried Braje, Thomas ERHARD +9 more 2017-02-21
9540376 Hexahydrodiazepinoquinolines carrying a substituted alkyl radical Gisela Backfisch, Margaretha Henrica Maria Bakker, Günter BLAICH, Wilfried Braje, Thomas ERHARD +7 more 2017-01-10
9475808 Inhibitor compounds of phosphodiesterase type 10A Hervé Geneste, Michael Ochse, Berthold Behl, Loic Laplanche, Jurgen Dinges +1 more 2016-10-25
9464072 Treatment of central nervous system disorders R. Scott Bitner, Kaitlin E. Browman, Michael E. Brune, Yixian Long, Jurgen Dinges +17 more 2016-10-11
9464085 Inhibitor compounds of phosphodiesterase type 10A Hervé Geneste, Michael Ochse, Clarissa Jakob 2016-10-11
9388180 Inhibitor compounds of phosphodiesterase type 10A Hervé Geneste, Michael Ochse, Clarissa Jakob, Maricel Torrent 2016-07-12
9388141 Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptor Andreas Haupt, Jurgen Dinges, Liliane Unger, Karsten Wicke, Robert Van Waterschoot +1 more 2016-07-12
9388148 Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptor Andreas Haupt, Jurgen Dinges, Liliane Unger, Karsten Wicke, Robert Van Waterschoot +1 more 2016-07-12
9376396 Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptor Andreas Haupt, Jurgen Dinges, Liliane Unger, Karsten Wicke, Robert Van Waterschoot +2 more 2016-06-28
9273068 Substituted isoquinolines and phthalazines as inhibitors of phosphodiesterase type 10A Hervé Geneste, Michael Ochse, Sean Colm Turner, Berthold Behl, Loic Laplanche +3 more 2016-03-01
9200005 Inhibitor compounds of phosphodiesterase type 10A Katja Jantos, Michael Ochse, Hervé Geneste, Jayne Froggett, Clarissa Jakob +1 more 2015-12-01
9169253 Tricyclic quinoline and quinoxaline derivatives Hannes Fiepko KOOLMAN, Wilfried Braje, Helmut Mack, Andreas Haupt, Ana-Lucia Relo +3 more 2015-10-27
9163019 Inhibitor compounds of phosphodiesterase type 10A Hervé Geneste, Michael Ochse, Berthold Behl, Loic Laplanche, Jurgen Dinges +1 more 2015-10-20
8969552 Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor Andreas Haupt, Liliane Unger, Sean Colm Turner, Wilfried Braje, Roland Grandel +1 more 2015-03-03
8940902 Treatment of central nervous system disorders R. Scott Bitner, Kaitlin E. Browman, Michael E. Brune, Yixian Chen, Jurgen Dinges +17 more 2015-01-27
8642642 Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor Roland Grandel, Wilfried Braje, Andreas Haupt, Sean Colm Turner, Udo Lange +2 more 2014-02-04
8507469 Azetidin compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor Thomas Schultz, Wilfried Braje, Sean Colm Turner, Andreas Haupt, Udo Lange +4 more 2013-08-13
8497273 Heterocyclic compounds suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor Roland Grandel, Wilfried Braje, Andreas Haupt, Sean Colm Turner, Udo Lange +1 more 2013-07-30